ZEISS MEL 90 Excimer Laser Gets FDA Nod For Myopia, Hyperopia and Mixed Astigmatism
The first major US approval for ZEISS in 2025 furthers its bid for laser vision correction dominance. ZEISS Medical Technology…
The first major US approval for ZEISS in 2025 furthers its bid for laser vision correction dominance. ZEISS Medical Technology…
![[B+L] CBC Exhibition Booth Thumbnail](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/01/BL-CBC-Exhibition-Booth-Thumbnail-579x326.png)
![[Appasamy] HQ Launch Promotional Video thumbnail Inside the Powerhouse The Grand Opening of Appasamy Associates’ Global HQ in Chennai (2)](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/01/Appasamy-HQ-Launch-Promotional-Video-thumbnail-Inside-the-Powerhouse-The-Grand-Opening-of-Appasamy-Associates-Global-HQ-in-Chennai-2-579x326.png)
![[TFG] ESCRS Refractive Surgery Series ep. 1 thumbnail TFG Refractive Surgery Video Inte](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/02/TFG-ESCRS-Refractive-Surgery-Series-ep.-1-thumbnail-TFG-Refractive-Surgery-Video-Inte-579x326.png)
![[Internal] Data Visualization Video Dr. Gus Gazzard thumbnail Science Saves Sight Prof. Gus Gazzard on SLT vs. Drops for Glaucoma and IOP Control](https://staging.cake.bantampoint.org/wp-content/uploads/sites/3/2025/01/Internal-Data-Visualization-Video-Dr.-Gus-Gazzard-thumbnail-Science-Saves-Sight-Prof.-Gus-Gazzard-on-SLT-vs.-Drops-for-Glaucoma-and-IOP-Control-579x326.jpg)
